Literature DB >> 19421848

Reactions to and desire for prognostic testing in choroidal melanoma patients.

Tammy M Beran1, Tara A McCannel, Annette L Stanton, Bradley R Straatsma, Barry L Burgess.   

Abstract

To determine if choroidal melanoma patients want cytogenetic prognostic information. Ninety-nine choroidal melanoma patients completed a questionnaire regarding their opinions about receiving prognostic information. The perceived usefulness of prognostic information was evaluated in patients who had undergone cytogenetic testing. Depressive symptoms, quality of life, and interest in supportive counseling during test receipt were assessed. Ninety-seven percent of respondents reported that they would have wanted prognostic information at the time of their treatment and 98% of respondents reported that supportive counseling should be offered when prognostic information is given. Patients who had received a more favorable prognostic result were more likely to endorse the usefulness of cytogenetic testing than were patients who had received a less favorable prognostic result. Psychological status did not vary significantly as a function of cytogenetic test result. Prognostic information was important to patients with choroidal melanoma, even in the absence of prophylactic measures which might improve prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19421848     DOI: 10.1007/s10897-009-9223-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  32 in total

1.  Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization.

Authors:  F Tschentscher; G Prescher; M Zeschnigk; B Horsthemke; D R Lohmann
Journal:  Cancer Genet Cytogenet       Date:  2000-10-01

2.  Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis.

Authors:  K Sisley; I G Rennie; M A Parsons; R Jacques; D W Hammond; S M Bell; A M Potter; R C Rees
Journal:  Genes Chromosomes Cancer       Date:  1997-05       Impact factor: 5.006

3.  Molecular prognostic testing in uveal melanoma: has it finally come of age?

Authors:  J William Harbour
Journal:  Arch Ophthalmol       Date:  2007-08

4.  Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

Authors:  Michael D Onken; Lori A Worley; Rosa M Dávila; Devron H Char; J William Harbour
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

5.  Incidence of noncutaneous melanomas in the U.S.

Authors:  Colleen C McLaughlin; Xiao-Cheng Wu; Ahmedin Jemal; Howard J Martin; Lisa M Roche; Vivien W Chen
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

6.  Adults seeking presymptomatic gene testing for Huntington disease.

Authors:  J K Williams; D L Schutte; C A Evers; C Forcucci
Journal:  Image J Nurs Sch       Date:  1999

7.  In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy.

Authors:  E Midena; L Bonaldi; R Parrozzani; E Tebaldi; B Boccassini; S Vujosevic
Journal:  Eur J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.597

Review 8.  Considerations in using tumor markers: what the psycho-oncologist needs to know.

Authors:  D L Fertig; D F Hayes
Journal:  Psychooncology       Date:  2001 Sep-Oct       Impact factor: 3.894

9.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

10.  High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.

Authors:  Tara A Young; Barry L Burgess; Nagesh P Rao; Michael B Gorin; Bradley R Straatsma
Journal:  Mol Vis       Date:  2007-12-21       Impact factor: 2.367

View more
  22 in total

1.  Two-year patient-reported outcomes following treatment of uveal melanoma.

Authors:  L Hope-Stone; S L Brown; H Heimann; B Damato; P Salmon
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

Review 2.  Choroidal biopsies; a review and optimised approach.

Authors:  R N Hussain; B Damato; H Heimann
Journal:  Eye (Lond)       Date:  2022-08-08       Impact factor: 4.456

3.  Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma.

Authors:  Sharon A Cook; Bertil Damato; Ernie Marshall; Peter Salmon
Journal:  Health Expect       Date:  2010-10-28       Impact factor: 3.377

4.  Quality of life and cancer-related needs in patients with choroidal melanoma.

Authors:  Joshua F Wiley; Kelsey Laird; Tammy Beran; Tara A McCannel; Annette L Stanton
Journal:  Br J Ophthalmol       Date:  2013-09-13       Impact factor: 4.638

5.  Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.

Authors:  S Thomas; C Pütter; S Weber; N Bornfeld; D R Lohmann; M Zeschnigk
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

6.  Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent in situ Hybridization and Multiplex Ligation Probe Amplification in Fine-Needle Aspiration Biopsy Specimens of Uveal Melanoma.

Authors:  Michael A Klufas; Elizabeth Richter; Sujit Itty; Christian Moreno; Colin A McCannel; Tara A McCannel
Journal:  Ocul Oncol Pathol       Date:  2017-06-14

7.  The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.

Authors:  J William Harbour; Royce Chen
Journal:  PLoS Curr       Date:  2013-04-09

8.  Survival analysis following enucleation for uveal melanoma.

Authors:  Guy S Negretti; Sarega Gurudas; Beatrice Gallo; Bertil Damato; Amit K Arora; Sobha Sivaprasad; Mandeep S Sagoo
Journal:  Eye (Lond)       Date:  2021-08-02       Impact factor: 4.456

9.  Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma.

Authors:  Melinda Y Chang; Nagesh P Rao; Barry L Burgess; Lariza Johnson; Tara A McCannel
Journal:  Mol Vis       Date:  2013-09-07       Impact factor: 2.367

10.  Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.

Authors:  Yesim Erim; Jennifer Scheel; Anja Breidenstein; Claudia Hd Metz; Dietmar Lohmann; Hans-Christoph Friederich; Sefik Tagay
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.